Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Infinity Pharmaceuticals
(NQ:
INFI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Infinity Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
Next >
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 16, 2023
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.
Via
Benzinga
Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
June 16, 2023
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #11672834 for "Prebiotic Compositions And Methods Of Use...
Via
Benzinga
Infinity Pharmaceuticals Earnings Perspective: Return On Capital Employed
March 29, 2023
Via
Benzinga
Infinity Pharmaceuticals's Return On Capital Employed Overview
December 23, 2022
Via
Benzinga
MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
June 15, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI
June 14, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2023 Annual Meeting of the American Association of Cancer Research
April 13, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Infinity Pharmaceuticals Reports Full Year 2022 Financial Results
March 28, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
March 14, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 03, 2023
Via
Benzinga
INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI
February 27, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
February 24, 2023
Via
Benzinga
Crude Oil Rises 1.5%; NeoGenomics Shares Spike Higher
February 23, 2023
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded down 0.03% to 33,036.50 while the NASDAQ rose 0.46% to...
Via
Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 23, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 23, 2023
Via
Benzinga
US Stocks Turn Lower; Dow Drops 150 Points
February 23, 2023
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.47% to 32,889.30 while the NASDAQ fell 0.47% to 11,452.63. The S&P 500...
Via
Benzinga
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
February 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 23, 2023
Via
Benzinga
INFI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Infinity Pharmaceuticals, Inc. Is Fair to Shareholders
February 23, 2023
From
Halper Sadeh LLC
Via
Business Wire
MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates
February 23, 2023
From
MEI Pharma, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 13, 2022
Via
Benzinga
Infinity Pharmaceuticals to Participate in Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Upgrades
Via
Benzinga
Infinity Pharma Posts 52% Increase In One-Year Progression Free Survival Rate In Breast Cancer Patients
November 14, 2022
Via
Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.